CA2201931A1 - Mixture of phospholipid-containing fats and lcp fatty acids - Google Patents

Mixture of phospholipid-containing fats and lcp fatty acids

Info

Publication number
CA2201931A1
CA2201931A1 CA002201931A CA2201931A CA2201931A1 CA 2201931 A1 CA2201931 A1 CA 2201931A1 CA 002201931 A CA002201931 A CA 002201931A CA 2201931 A CA2201931 A CA 2201931A CA 2201931 A1 CA2201931 A1 CA 2201931A1
Authority
CA
Canada
Prior art keywords
mixture
phospholipid
fatty acids
containing fats
lcp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002201931A
Other languages
French (fr)
Other versions
CA2201931C (en
Inventor
Gerhard Kohn
Gunther Sawatzki
Friedrich Schweikhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2201931A1 publication Critical patent/CA2201931A1/en
Application granted granted Critical
Publication of CA2201931C publication Critical patent/CA2201931C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
  • Dairy Products (AREA)
  • Edible Oils And Fats (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

A formula food and a fat mixture for such a formula food are provided.
In the fat mixture, arachidonic acid and docosahexaenoic acid are present both in the form of phospholipids and also in the form of triglycerides.
CA002201931A 1994-10-05 1995-10-02 Mixture of phospholipid-containing fats and lcp fatty acids Expired - Fee Related CA2201931C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4435535.1 1994-10-05
DE4435535 1994-10-05
PCT/EP1995/003899 WO1996010922A1 (en) 1994-10-05 1995-10-02 Mixture of phospholipid-containing fats and lcp fatty acids

Publications (2)

Publication Number Publication Date
CA2201931A1 true CA2201931A1 (en) 1996-04-18
CA2201931C CA2201931C (en) 2004-08-10

Family

ID=6529982

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002201931A Expired - Fee Related CA2201931C (en) 1994-10-05 1995-10-02 Mixture of phospholipid-containing fats and lcp fatty acids

Country Status (8)

Country Link
EP (1) EP0784437B1 (en)
JP (1) JPH10508193A (en)
AT (1) ATE167983T1 (en)
CA (1) CA2201931C (en)
DE (1) DE59502779D1 (en)
DK (1) DK0784437T3 (en)
ES (1) ES2118629T3 (en)
WO (1) WO1996010922A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095435A1 (en) 2008-01-30 2009-08-06 Bnlfood Investments Sarl Lecithin based composition and its use in food

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
HUP0300236A3 (en) 1997-02-21 2003-09-29 Univ Tennessee Res Corp Knoxvi Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation
SE9702630D0 (en) * 1997-07-07 1997-07-07 Scotia Lipidteknik Ab Satiety product
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6495599B2 (en) 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
EP1181870A1 (en) * 2000-08-22 2002-02-27 Belovo Eggs & Egg Products Manufactured lipid emulsion having an improved balanced dietary source of vitamin F
JP2003048831A (en) 2001-08-02 2003-02-21 Suntory Ltd Composition having preventing and ameliorating action on symptom or disease caused by decrease in brain function
PT1542670E (en) * 2002-09-24 2013-07-11 Suntory Holdings Ltd Composition containing arachidonic acid alone or in combination with docosahexaenoic acid for enhancing cognitive abilities in adults
CA2530170A1 (en) * 2003-06-24 2005-01-06 University Of Kansas Medical Center Infant formula
JP4993852B2 (en) 2004-09-17 2012-08-08 サントリーホールディングス株式会社 Composition having a preventive or ameliorating effect on symptoms or diseases accompanied by behavioral abnormalities caused by stress
JP5967855B2 (en) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 Composition having an activity of reducing daytime activity and / or depressive symptoms
VN24011A1 (en) * 2006-08-29 2010-10-25 Martek Biosciences Corp Use of DPA(n-6) oils in infant formula
WO2008081989A1 (en) 2006-12-28 2008-07-10 Suntory Holdings Limited Nerve regeneration agent
MX2010004820A (en) 2007-11-01 2010-08-10 Enzymotec Ltd Lipid mixture for infant nutrition.
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
US20130172286A1 (en) 2010-03-31 2013-07-04 Vegenat, S.A. Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
WO2011121150A1 (en) 2010-03-31 2011-10-06 Vegenat, S.A. Enteral or oral food product intended, in particular, for nutrition and for the prevention and improvement of neurological alterations, neurodegenerative alterations or cognitive disorders
WO2015069097A1 (en) 2013-11-08 2015-05-14 N.V. Nutricia Efficacy of dietary dha-phospholipid for brain dha and dpa accretion in neonates
US20220369660A1 (en) 2019-09-24 2022-11-24 Societe Des Produits Nestle S.A. Glycyrrhiza and the prevention of lc-pufa oxidation
WO2021255061A1 (en) 2020-06-17 2021-12-23 Société des Produits Nestlé S.A. Stabilization of lc-pufas by side stream product from green coffee decaffeination
WO2022143781A1 (en) * 2020-12-29 2022-07-07 丰益(上海)生物技术研发中心有限公司 Structured emulsion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2033193B1 (en) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro FAT MIXTURE FOR CHILD AND ADULT NUTRITION.
ES2157898T3 (en) * 1991-01-24 2001-09-01 Martek Corp MICROBIAL OILS AND USES OF THE SAME.
SE9101642D0 (en) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab phospholipids
DE4219360C2 (en) * 1992-06-12 1994-07-28 Milupa Ag Process for the production of lipids with a high proportion of long-chain, highly unsaturated fatty acids
DE4407933A1 (en) * 1993-03-15 1994-09-22 Sueddeutsche Kalkstickstoff Process for isolating lipid fractions from pulverulent egg products
DE19505305A1 (en) * 1994-02-24 1995-08-31 Milupa Ag Stabilised polyunsatd. lipid compsns.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095435A1 (en) 2008-01-30 2009-08-06 Bnlfood Investments Sarl Lecithin based composition and its use in food
EP2100897A1 (en) 2008-01-30 2009-09-16 BNLfood Investments SARL Lecithin based composition and its use in food
CN102015735A (en) * 2008-01-30 2011-04-13 Bnl食品投资有限公司 Compositions based on lecithin and their use in food

Also Published As

Publication number Publication date
CA2201931C (en) 2004-08-10
ATE167983T1 (en) 1998-07-15
EP0784437B1 (en) 1998-07-08
JPH10508193A (en) 1998-08-18
EP0784437A1 (en) 1997-07-23
DK0784437T3 (en) 1999-04-19
ES2118629T3 (en) 1998-09-16
DE59502779D1 (en) 1998-08-13
WO1996010922A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
DK0784437T3 (en) Phospholipid-containing fat mixture with LCP fatty acids
CA2127012A1 (en) A lipidic composition intended for use as a food or in food products
CA2208817A1 (en) Dietetically balanced milk product
Barber et al. Lipid metabolism in the lactating mammary gland
AU7175496A (en) Edible fat-spread
CA2382262A1 (en) A nutritional supplement for lowering serum triglyceride and cholesterol levels
CA2245483A1 (en) Fat based food products comprising sterols
CA2245467A1 (en) Aqueous dispersions or suspensions
CA2281706A1 (en) Methods and compositions for reducing the incidence of necrotizing enterocolitis
CA2239806A1 (en) Lipid composition for infant formula and method of preparation
KR940018091A (en) Prescriptions Containing Unsaturated Fatty Acids
AU2296388A (en) Tailored triglycerides having improved autoignition characteristics
CA2159058A1 (en) Inhibition of helicobacter
CA2147302A1 (en) A lipid composition for normalizing injury
CA2128706A1 (en) Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain
CA2197838A1 (en) Mouthfeel and lubricity enhancing composition
AU4029789A (en) Preparation of esterified propoxylated glycerin from free fatty acids
AU3131695A (en) Chocolate products with sucrose fatty acid polyester fat substitutes
AU1808295A (en) Hydrogenation of unsaturated fats, fatty acids or fatty acid esters
AU4046693A (en) Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
DE3470277D1 (en) Dietetic composition
AU2441400A (en) Stabilized lipidic composition, method for the preparation thereof and nutritional product containing the same
CA2186767A1 (en) Fractionation of triglyceride oils
AU3776595A (en) Process for the hydrolysis of the triglycerides of polyunsaturated fatty acids
AU3543097A (en) Process for preparation of branched fatty acids

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed